Saniona AB (STU:30S) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


STU:30S Saniona AB STU:30S
61 GF Score
Price €1.13
GF Value €2.44
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Saniona AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

STU:30S vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Saniona AB's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Saniona AB Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Saniona AB's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Saniona AB's Margin of Safety % (DCF Earnings Based) falls into.


STU:30S
61GF Score
Saniona AB STU:30S
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Saniona AB (STU:30S) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of €1.13 is trading 53.6% below its estimated GF Value™ of €2.44. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for STU:30S:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €2.44 vs. price of €1.13 (53.6% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the STU:30S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
61GF Score

Get the complete analysis for STU:30S

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.13
Price
€2.44
GF Value